Free Trial
NASDAQ:AMIX

Autonomix Medical 11/8/2024 Earnings Report

Autonomix Medical logo
$1.12 +0.02 (+1.82%)
Closing price 04:00 PM Eastern
Extended Trading
$1.10 -0.02 (-1.34%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Autonomix Medical EPS Results

Actual EPS
-$2.47
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Autonomix Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Autonomix Medical Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Autonomix Medical's next earnings date is estimated for Friday, November 14, 2025, based on past reporting schedules.

Conference Call Resources

Autonomix Medical Earnings Headlines

Autonomix Medical Raises Stock Sales Price
Autonomix Medical Enters $15M Purchase Agreement
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
Autonomix Medical Inc News (AMIX) - Investing.com
See More Autonomix Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Autonomix Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Autonomix Medical and other key companies, straight to your email.

About Autonomix Medical

Autonomix Medical (NASDAQ:AMIX), a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

View Autonomix Medical Profile

More Earnings Resources from MarketBeat